ppENK Gene Methylation Status in the Development of Pancreatic Carcinoma

Abulaizi, M., Tomonaga, T., Satoh, M., Sogawa, K., Matsushita, K., Kodera, Y., Obul, J., Takano, S., Yoshitomi, H., Miyazaki, M., & Nomura, F. (2011). The Application of a Three-Step Proteome Analysis for Identification of New Biomarkers of Pancreatic Cancer. International Journal of Proteomics, 2011(), 172-184. https://doi.org/10.1155/2011/628787
賴伊貞（2005）。Cytokine Genetic Polymorphisms and Risk of Hepatocellular Carcinoma〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2005.02129
Sun, T., Kong, X., Du, Y., & Li, Z. (2014). Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications. Gastroenterology Research and Practice, 2014(), 338-348-047. https://doi.org/10.1155/2014/386561
Yang, Y. C. (2017). Non-metabolic Function of PKM2 in the Progression of Lung Cancer and Pancreatic Cancer [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201700692
Lau, S. H. (2007). Identification and characterization of key genes involved in the development and progression of hepatocellular carcinoma [doctoral dissertation, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200012800